These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7679644)

  • 1. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
    Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A
    Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.
    Panina-Bordignon P; Tan A; Termijtelen A; Demotz S; Corradin G; Lanzavecchia A
    Eur J Immunol; 1989 Dec; 19(12):2237-42. PubMed ID: 2481588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell recognition of allopeptides in context of syngeneic MHC.
    Liu Z; Braunstein NS; Suciu-Foca N
    J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS; van Rood JJ; Termijtelen A
    Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
    Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
    J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of several DR-restricted tetanus toxin T cell epitopes.
    Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
    J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.
    Wiertz EJ; van Gaans-van den Brink JA; Schreuder GM; Termijtelen AA; Hoogerhout P; Poolman JT
    J Immunol; 1991 Sep; 147(6):2012-8. PubMed ID: 1716291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.